V
venBio Partners LLC Portfolio Analytics
Investment Analysis & Holdings Breakdown
Comprehensive portfolio analytics for venBio Partners LLC with $176.4M in long positions as of Q3 2025, 88% allocated to Healthcare, and 100% concentrated in top 10 positions.
- Portfolio Value
- $176.4M
- Top 10 Concentration
- 100%
- Top Sector
- Healthcare (88%)
- US Exposure
- 34%
- Market Cap Focus
- Small Cap
- Countries
- 2
Composition Analysis
Portfolio breakdown by sector, industry, and market capitalization
Sector Allocation
Industry Breakdown
1 industry across all sectors
Filter by Sector
Select a sector to filter industries
Market Cap Distribution
Portfolio Concentration
Geographic Exposure
Portfolio breakdown by country of incorporation
Domestic (US)
International
Countries
Largest Int'l Market
Holding Behavior
Investment patterns and position management analysis
Portfolio Stability & Commitment
- Avg. Top 10
- 11.7 quarters
- Avg. Top 20
- 11.7 quarters
- Avg. All Positions
- 11.7 quarters
- Median Holding Period
- 11.5 quarters
- Persistence Rate
- 83.33%
- Persistent Holdings Weight
- 95.64%
- Persistent Positions
- 5
- Longest Held
Harmony Biosciences Holdings, Inc. Common StockHRMY - 20 quarters
Position Sizing & Influence
Current Quarter
- Avg. New Position
- 0.000%
- Avg. Position Weight
- 16.67%
- Largest Position
Pharvaris N.V. Ordinary SharesPHVS - 65.62%- Largest Ownership Stake
ALX Oncology Holdings Inc. Common StockALXO - 18.11%- Avg. Ownership Stake
- 7.28%
- Ownership Stake >5%
- 2
- Ownership Stake >1%
- 5
Historical (Since Q4 2018)
- Avg. New Position
- 24.78%
- Avg. Ownership Stake
- 13.54%
- Largest Position
Apellis Pharmaceuticals, Inc. Common StockAPLS - 79.68% (Q4 2018)- Largest Ownership Stake
- ALX Oncology Holdings Inc. Common StockALXO - 23.95% (Q4 2020)
Portfolio Turnover
Current Quarter
- Turnover Ratio
- 2.5%
- Value Traded
- $4.37M
- Positions Added
- 0
- Positions Exited
- 0
Historical (Since Q4 2018)
- Avg. Turnover Ratio
- 13.8%
- Avg. Positions Added
- 1
- Avg. Positions Exited
- 1
- Highest Turnover
- 59.7%Q1 2024